Validation of ADORA2A and GPR37 interaction in HEK‐293 cells and native tissue Validation of ADORA2A and GPR37 interaction in HEK‐293 cells and native.

Slides:

Advertisements

Similar presentations

C B *** Cal51 p21 BAX p53 actin PUMA Nutlin3a ABT wt A *** Le Pen et al., figure S mock ABT-737 Nutlin3a ABT-737.

Advertisements

Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Transcriptome Characterization of Estrogen-Treated.

Figure 8. Colocalization of β-Arrestin2-GFP with Internalized wt and S(483–498)A Mutant PTHRs HEK-wt PTHR and HEK-S(483–498)A PTHR cells were transiently.

Reduction in immune cell infiltration after stab wound injury in CCR2−/− mice increases proliferation at the injury site Reduction in immune cell infiltration.

Morphology of white adipose tissue and muscle in S1/3 KO mice of different ages Morphology of white adipose tissue and muscle in S1/3 KO mice of different.

Interaction between G Protein-Coupled Receptor 143 and Tyrosinase: Implications for Understanding Ocular Albinism Type 1 Elisabetta De Filippo, Anke.

SERCA2 is a functional adaptor for the alternative toll‐like receptor 9 (TLR9) signalling in cardiomyocytes Co‐immunoprecipitated TLR9 with SERCA2 antibody.

The N‐terminus and SH2 domain of SOCS‐1 contribute to inhibition of JAK1 and JAK2 kinase activity. The N‐terminus and SH2 domain of SOCS‐1 contribute to.

[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.

Differential accumulation of substrates in vivo

Volume 13, Issue 4, Pages (February 2003)

Disease‐causing mutations influence the association of CSPα with partner proteins Disease‐causing mutations influence the association of CSPα with partner.

Expression and regulation of MD-2s.

Volume 11, Issue 2, Pages (February 2010)

MCPH1 interacts with E2F1. MCPH1 interacts with E2F1. (A,B) HEK293 cells were left untreated (No tx) or treated with 300 ng/ml NCS for 4 h or 2 μM adriamycin.

Effects of GM1 on astroglial and microglial markers

DNA and membrane binding of MinD are interconnected.

Volume 7, Issue 5, Pages (June 2014)

Atp1a3 phosphomutants show alterations in subcellular localization.

Effects of missense mutations and small molecules on PPI detection with LuTHy Effects of missense mutations and small molecules on PPI detection with LuTHy.

The LuTHy procedure The LuTHy procedure Schematic representation of the workflow of the LuTHy method. Expression vectors encoding NL and PA‐mCit‐tagged.

Nec‐1 inhibits the phosphorylation and aggregation of tau

Lysozyme expression in isolated Paneth cells and linage tracing of Notch1+ cells Lysozyme expression in isolated Paneth cells and linage tracing of Notch1+

Volume 15, Issue 6, Pages (June 2012)

Molecular Therapy - Methods & Clinical Development

HMGB1 reverses mitochondrial DNA damage caused by mutant Atxn1 The mitochondrial DNA amplification assay with cerebellar tissue revealed that mitochondrial.

Volume 22, Issue 5, Pages (January 2018)

Disease‐associated human WDR11 mutations are functionally defective

ER stress response and susceptibility to apoptosis are regulated by TFEB and TFE3 ER stress response and susceptibility to apoptosis are regulated by TFEB.

Volume 18, Issue 11, Pages (March 2017)

Notch activation in Notch1 positive feedback knock‐out intestine organoids Notch activation in Notch1 positive feedback knock‐out intestine organoids Intestine.

QRT–PCR analysis of tissue‐specific candidate gene expression in response to reduced IIS qRT–PCR analysis of tissue‐specific candidate gene expression.

NDP52 promotes CHIKV infection in a species‐specific manner.

Melissa L. Ehlers, Barbara Celona, Brian L. Black Cell Reports

DOK7 gene therapy suppresses motor nerve terminal degeneration at the NMJ in ALS mice DOK7 gene therapy suppresses motor nerve terminal degeneration at.

Enhancement of receptor endocytosis, as well as cellular apoptosis, may explain the cooperative anti‐tumor actions of 3×mAbs and osimertinib Enhancement.

RB regulates half‐life and stability of Pdx‐1 protein.

Role of HER2 in mediating acquired resistance to EGFR inhibition.

Knock‐in mutation of the T1348N mutation that ablates GTP binding to LRRK2 abolishes Rab10 and biomarker phosphorylation Knock‐in mutation of the T1348N.

Validation of phosphatase hits mapping prediction on the optimized growth model. Validation of phosphatase hits mapping prediction on the optimized growth.

TIPI mediates rapid degradation of proteins in yeast.

Both E102Q and L95fs Sig1R variants are unstable and lose their abilities to control Ca2+ flux in Neuro2a cells Both E102Q and L95fs Sig1R variants are.

The CHCH domain is necessary for mitochondrial import of CHCHD10

Volume 42, Issue 4, Pages (April 2015)

Interaction of Gpr1/Gpa2 and Sch9.

Ubqln1 interacts with Ubqln4.

Activation of Drp1 by E2F5‐Drp1 complex enhances HPV‐E7/ceramide‐mediated lethal mitophagy Activation of Drp1 by E2F5‐Drp1 complex enhances HPV‐E7/ceramide‐mediated.

Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts.

ATAD1 physically interacts with the TA protein, GOS28, and is required to limit the level of mislocalized GOS28 on mitochondria in mammals Human dermal.

Volume 13, Issue 10, Pages (December 2015)

AS aggregates interact with SERCA in SH‐SY5Y cells

PRG‐1R346T: loss‐of‐function mutation reduced LPA internalization due to altered O‐glycosylation PRG‐1R346T: loss‐of‐function mutation reduced LPA internalization.

Volume 33, Issue 5, Pages (November 2010)

Single‐molecule dynamics of the active mutant, hDIA1(R1204X), in XTC cells Single‐molecule dynamics of the active mutant, hDIA1(R1204X), in XTC cells A–DGFP‐tagged.

RIF1 interacts with protein phosphatase 1 isoforms

Ankyrin domain residues permit activation of LRRK2 by Rab29

Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor by Gauthami Jalagadugula, Lawrence.

MET/β-catenin complexes during synapse development.

Therapy-induced senescence of primary cells.

Leptin and amylin signaling.

Growth Factor-Dependent Trafficking of Cerebellar NMDA Receptors via Protein Kinase B/Akt Phosphorylation of NR2C Bo-Shiun Chen, Katherine W. Roche

Volume 21, Issue 9, Pages (November 2017)

Lysine residues in the cytoplasmic region of TfR are involved in the MARCH8-induced downregulation of TfR. Lysine residues in the cytoplasmic region of.

WT MARCH8, but not the CS mutant, specifically ubiquitinates and downregulates TfR. WT MARCH8, but not the CS mutant, specifically ubiquitinates and downregulates.

Fig. 7. Analysis of dFMRP kinetics in dFMRP granules by FRAP

PTZ-induced neuronal activity visualized by IEGs

Mutant MFN2 proteins have normal half-lives and are properly localized to mitochondria. Mutant MFN2 proteins have normal half-lives and are properly localized.

PARP‐1 activity is reduced in NEDP1 KO cells

Irreplaceability of Neuronal Ensembles after Memory Allocation

Association of TCTP with Pim-3 in human pancreatic cancer cell lines.

Presentation transcript:

Validation of ADORA2A and GPR37 interaction in HEK‐293 cells and native tissue Validation of ADORA2A and GPR37 interaction in HEK‐293 cells and native tissue ACo‐localization of ADORA2A and GPR37 in HEK‐293 cells transiently transfected with ADORA2A‐CFP, GPR37‐YFP, or ADORA2A‐CFP plus GPR37‐YFP. Transfected cells were analyzed by confocal microscopy. Merged images reveal co‐distribution of ADORA2A‐CFP and GPR37‐YFP (yellow) and DAPI‐stained nuclei (blue). Scale bar: 10 μm.BCo‐immunoprecipitation of ADORA2A and GPR37 from HEK‐293 transiently transfected with ADORA2A (lane 1), GPR37‐YFP (lane 2) or ADORA2A plus GPR37‐YFP (lane 3) using a mouse anti‐GFP antibody (2 μg/ml) or a mouse anti‐A2AR antibody (1 μg/ml). The crude extracts (Lysate) and immunoprecipitates (IP) were analyzed by SDS–PAGE and immunoblotted (IB) using a rabbit anti‐GPR37 (1/2,000) or rabbit anti‐A2AR antibody (1/2,000).C, DBRET saturation experiments between GPR37‐Rluc and ADORA2A‐YFP (black circle) or ADORA1‐YFP (white circle; C), or ADORA2A‐Rluc and GPR37‐YFP (black circle) or CD4R‐YFP control (white circle; D) in transiently transfected HEK‐293. Plotted on the x‐axis is the fluorescence value obtained from the YFP, normalized with the luminescence value of the Rluc constructs 10 min after h‐coelenterazine (5 μM) incubation, and on the y‐axis the corresponding BRET ratio (×1,000). mBU, mBRET units. Data shown are from three independent experiments.ECell surface expression of HEK‐293 cells transiently transfected with cDNA encoding ADORA2A (lane 1), GPR37‐YFP (lane 2) or ADORA2A plus GPR37‐YFP (lane 3). Cell surface proteins were biotinylated and crude extracts (whole cell) and biotinylated proteins were subsequently analyzed by SDS–PAGE and immunoblotted (IB) using a rabbit anti‐GPR37 antibody (1/2,000) or a rabbit anti‐A2AR antibody (1/2,000).FCell surface expression of HEK‐293 cells transiently transfected with cDNA encoding ADORA1 (lane 1), GPR37‐YFP (lane 2), or ADORA1 plus GPR37‐YFP (lane 3). Cell surface proteins were biotinylated and crude extracts (whole cell) and biotinylated proteins were subsequently analyzed by SDS‐PAGE and immunoblotted (IB) using a rabbit anti‐GPR37 antibody (1/2,000) or a rabbit anti‐A1R antibody (1/2,000).GCo‐immunoprecipitation of ADORA2A and GPR37 from C57BL/6J wild‐type (GPR37+/+) and mutant (GPR37−/−) mice striatum using a rabbit anti‐FLAG antibody (4 μg/ml; lane 1) or a rabbit anti‐GPR37 antibody (4 μg/ml; lane 2). The immunoprecipitates (IP) were analyzed by SDS‐PAGE and immunoblotted (IB) using a rabbit anti‐GPR37 (1/2,000) or mouse anti‐A2AR antibody (1/2,000).HInvolvement of GPR37 in haloperidol‐induced catalepsy. The influence of systemic injection of ADORA2A antagonist SCH 58261 (1 mg/kg, i.p.) on the catalepsy induced by haloperidol (1.5 mg/kg i.p.) was assessed in both WT (GPR37+/+) and mutant (GPR37−/−) mice as described in Materials and Methods. The data indicate the mean ± SEM (n = 6 per group). Asterisks denote data significantly different from the haloperidol‐treated mice: **P < 0.01 and ***P < 0.001 by one‐way ANOVA with Bonferroni multiple comparison post hoc test. In the GPR37−/− mice, the haloperidol plus SCH 58261 group were not significantly different (P > 0.05) from the control (i.e. SCH 58261 alone). ¥P < 0.01 by two‐way ANOVA with Bonferroni multiple comparison post hoc test for genotype and treatment comparisons. Kate Sokolina et al. Mol Syst Biol 2017;13:918 © as stated in the article, figure or figure legend